This genome-wide CRISPR screen showed that blocking the vitronectin (Vtn)-complement C1Q binding protein (C1qbp) interaction could increase macrophage phagocytosis, inhibiting tumour progression in vivo. The gene discussed is C1QBP; the disease is neoplasm.